23andMe Raises $82.5M in Private Financing

Dec 29, 2020

|

NEW YORK — 23andMe has raised $82.5 million through an equity sale, according to a filing late last week with the US Securities and Exchange Commission.

According to the filing, 23andMe offered a total of $85 million worth of equity.

The firm confirmed that the Series F round was led by Sequoia Capital and NewView Capital, which was reported yesterday by Bloomberg.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Mix of Human and Monkey

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

Fetal Tissue Policy Changes Expected

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

Science Papers on Approach to Isolate DNA from Sediment, Algorithm to Construct Signaling Networks

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Sequencing the Zoo

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.

Featured White Papers

Congenica Enables Five Minute Diagnosis of Previously Unsolved Case

Congenica CNV Calling for Exomes Whitepaper

Congenica Splice Site Finder White Paper

Expediting an Accurate Diagnosis through Streamlined Clinical Workflows

Apr

21

Featured Webinar

Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies

This webinar, the first in a “Meet the Authors” series sponsored by Mission Bio, will discuss the application of single-cell analysis to decipher clonal evolution across several stages of disease development in myeloid malignancies.

Apr

22

Featured Webinar

Single-Cell Genomics Decodes the Developing Human Immune System

The human immune system is extremely complex, comprised of multiple cell types and states interacting in myriad ways to produce diverse cellular ecosystems.

Apr

29

Featured Webinar

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May

12

Featured Webinar

SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19

This webinar will discuss a recent study that characterized the relationships between SARS-CoV-2 RNAemia and disease severity, clinical deterioration, and extrapulmonary complications (EPCs).

Menu

23andMe Raises $82.5M in Private Financing

To read the full story....

Breaking News

Autoimmune Disease Risk Tied to Genetic Variation in Transcription Factor Binding

Columbia University-led Study Highlights Bionano Optical Genome Mapping Concordance with Cytogenetics

People in the News: New Appointments at ACMG, InterVenn Biosciences, Castle Biosciences, More

In Brief This Week: Twist Bioscience, Ambry Genetics, Infinity BiologiX, and More

Biden Administration Commits $1.7B to SARS-CoV-2 Variant Sequencing, Surveillance

Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel

The Scan

Mix of Human and Monkey

Fetal Tissue Policy Changes Expected

Science Papers on Approach to Isolate DNA from Sediment, Algorithm to Construct Signaling Networks

Sequencing the Zoo

Featured White Papers

Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies

Single-Cell Genomics Decodes the Developing Human Immune System

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19

What's Popular?

Columbia University-led Study Highlights Bionano Optical Genome Mapping Concordance with Cytogenetics

Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches

DiaSorin to Acquire Luminex for $1.8B

Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel

Arcedi Biotech Introduces NIPT Analyzing DNA From Rare Fetal Cells in Maternal Blood

Sponsorships